Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
MANAGEMENT OF HYPERTENSION AND HYPERTENSIVE EMERGENCIES coverClinical notesMANAGEMENT OF HYPERTENSION AND HYPERTENSIVE EMERGENCIESDr. Kayima·Cardiology· 38 pagesThis document provides a comprehensive overview of the management strategies for hypertension and hypertensive emergencies, including case presentations and treatment protocols.
ATRIAL FIBRILLATION AND HEART FAILURE: NOVEL INSIGHTS INTO THE CHICKEN AND EGG DILEMMA coverClinical reviewsATRIAL FIBRILLATION AND HEART FAILURE: NOVEL INSIGHTS INTO THE CHICKEN AND EGG DILEMMADepartment of Internal Medicine II, University Medical Centre Regensburg; Clinic for Cardiology and Pneumology, Georg-August University Göttingen·Cardiology· 3 pagesThis document explores the complex relationship between atrial fibrillation (AF) and heart failure, highlighting how these two conditions can exacerbate each other and affect patient prognosis.
PROPOSED NEW CLASSIFICATION FOR ACUTE CORONARY SYNDROME coverClinical reviewsPROPOSED NEW CLASSIFICATION FOR ACUTE CORONARY SYNDROMEUConn Health, Texas Tech University Health Sciences Center, Cedars-Sinai Smidt Heart Institute·Cardiology· 2023· 5 pagesThis document presents a new classification for acute coronary syndrome (ACS) that emphasizes the need for immediate reperfusion in certain cases. It discusses the limitations of current classifications and proposes an updated framework based on recent evidence.
EFFICACY AND SAFETY OF PRASUGREL COMPARED WITH CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES: RESULTS OF TRITON-TIMI 38 TRIALS coverClinical reviewsEFFICACY AND SAFETY OF PRASUGREL COMPARED WITH CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES: RESULTS OF TRITON-TIMI 38 TRIALSDipartimento Cardiovascolare, Ospedale Civile di Legnano, Milan, Italy·Cardiology· 2009· 7 pagesThis document reviews the efficacy and safety of prasugrel compared to clopidogrel in patients with acute coronary syndromes, highlighting the results of the TRITON-TIMI 38 trial.
HYPERTENSIVE CRISIS: AN UPDATE ON CLINICAL APPROACH AND MANAGEMENT coverClinical reviewsHYPERTENSIVE CRISIS: AN UPDATE ON CLINICAL APPROACH AND MANAGEMENTHospital·Cardiology· 10 pagesThis document reviews current concepts on hypertensive crisis (HTN-C), focusing on epidemiology, causes, pathophysiology, and prognosis, while offering a practical management approach.
STATIN USE IS ASSOCIATED WITH LOWER RISK OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION coverClinical reviewsSTATIN USE IS ASSOCIATED WITH LOWER RISK OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATIONUniversity of Hong Kong, China·Cardiology· 2023· 3 pagesThis study evaluates the association between statin use and the incidence of stroke and transient ischaemic attack in patients diagnosed with atrial fibrillation, highlighting the protective effects of long-term statin therapy.
SGLT2 INHIBITORS IN PATIENTS WITH HEART FAILURE AND CHRONIC KIDNEY DISEASE coverClinical reviewsSGLT2 INHIBITORS IN PATIENTS WITH HEART FAILURE AND CHRONIC KIDNEY DISEASECopenhagen University Hospital Rigshospitalet·Cardiology· 3 pagesThis document discusses the rapid transition of SGLT2 inhibitors from auxiliary glucose-lowering medications to essential treatments for type 2 diabetes, heart failure, and chronic kidney disease, highlighting their benefits and challenges in implementation.
ATRIAL FIBRILLATION IN ADULTS: USE OF ORAL ANTICOAGULANTS coverClinical reviewsATRIAL FIBRILLATION IN ADULTS: USE OF ORAL ANTICOAGULANTSWarren J Manning, MD, Daniel E Singer, MD, Gregory YH Lip, MD, FRCPE, FESC, FACC·Cardiology· 2026· 39 pagesThis document discusses the long-term use of oral anticoagulation in patients with atrial fibrillation to reduce the risk of ischemic stroke and other embolic events.
INVASULAR ULTRASOUND-GUIDED VERSUS ANGIOGRAPHY-GUIDED PERCUTANEOUS CORONARY INTERVENTION IN UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: A SYSTEMATIC REVIEW coverClinical reviewsINVASULAR ULTRASOUND-GUIDED VERSUS ANGIOGRAPHY-GUIDED PERCUTANEOUS CORONARY INTERVENTION IN UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: A SYSTEMATIC REVIEWCardialysis, Cork University Hospital, Hospital Universitario Marques de Valdecilla, IRCCS Policlinico S. Donato, John Radcliffe Hospital·Cardiology· 10 pagesThis systematic review evaluates the evidence on intravascular ultrasound (IVUS) guidance versus angiography guidance in percutaneous coronary interventions (PCI) for unprotected left main coronary artery disease.
CARDIOVASCULAR MAGNETIC RESONANCE TO GUIDE DEFIBRILLATOR IMPLANTATION FOR LVEF OF 36% TO 50% coverClinical reviewsCARDIOVASCULAR MAGNETIC RESONANCE TO GUIDE DEFIBRILLATOR IMPLANTATION FOR LVEF OF 36% TO 50%null·Cardiology· 2023· 11 pagesThis study investigates whether the implantation of implantable cardioverter-defibrillators (ICDs) reduces sudden cardiac death or hemodynamically significant ventricular arrhythmia in patients with a left ventricular ejection fraction of 36% to 50% and myocardial scar.
WHAT TO KNOW ABOUT THE NEW BLOOD PRESSURE GUIDELINES coverClinical reviewsWHAT TO KNOW ABOUT THE NEW BLOOD PRESSURE GUIDELINESAmerican Heart Association, American College of Cardiology·Cardiology· 2025· 3 pagesThis document discusses the updates in the new high blood pressure guidelines for adults released by the American Heart Association and the American College of Cardiology, emphasizing earlier treatment and tighter control of blood pressure.
PAROXYSMAL ATRIAL FIBRILLATION coverClinical reviewsPAROXYSMAL ATRIAL FIBRILLATIONUpToDate, Inc.·Cardiology· 2026· 19 pagesThis document provides an overview of paroxysmal atrial fibrillation (PAF), including its management and treatment options.
MANAGEMENT OF HEART FAILURE coverLecture slidesMANAGEMENT OF HEART FAILUREnull·Cardiology· 2021· 30 pagesThis document provides a comprehensive overview of heart failure, including its definition, causes, pathophysiology, classification, symptoms, signs, investigations, and management strategies.
ATORVASTATIN, CARDIOVASCULAR EVENTS, AND DISABILITY-FREE SURVIVAL IN OLDER ADULTS coverClinical reviewsATORVASTATIN, CARDIOVASCULAR EVENTS, AND DISABILITY-FREE SURVIVAL IN OLDER ADULTSNEJM·Cardiology· 2026· 13 pagesThis study investigates the effectiveness and safety of atorvastatin for the primary prevention of cardiovascular events and the extension of disability-free survival among older adults.
ATRIAL FIBRILLATION: CLINICAL MANIFESTATIONS AND DIAGNOSIS coverClinical reviewsATRIAL FIBRILLATION: CLINICAL MANIFESTATIONS AND DIAGNOSISKapil Kumar, MD·Cardiology· 2025· 24 pagesThis document provides a comprehensive overview of the clinical presentation and diagnosis of atrial fibrillation (AF), the most common treated cardiac arrhythmia.
ATRIAL FIBRILLATION AND HEART FAILURE: MANAGEMENT coverClinical reviewsATRIAL FIBRILLATION AND HEART FAILURE: MANAGEMENTBrian Olshansky, MD·Cardiology· 2025· 34 pagesThis document focuses on the acute and long-term management and prognosis of atrial fibrillation in patients with heart failure, including those with reduced and preserved ejection fraction.
Intracoronary Low-Dose Thrombolysis in Primary PCI for STEM coverClinical reviewsIntracoronary Low-Dose Thrombolysis in Primary PCI for STEMKevin R. Bainey, MD, MSc·Cardiology· 2026· 3 pagesA systematic review and meta-analysis of randomized trials evaluating low‑dose intracoronary thrombolytics during primary percutaneous coronary intervention for ST‑elevation myocardial infarction.
IMPLICATIONS OF THE 2026 DYSLIPIDEMIA GUIDELINE FOR PRIMARY PREVENTION STATIN THERAPY coverClinical reviewsIMPLICATIONS OF THE 2026 DYSLIPIDEMIA GUIDELINE FOR PRIMARY PREVENTION STATIN THERAPYTimothy S. Anderson, MD, MAS; Linnea M. Wilson, MPH; Jeremy B. Sussman, MD, MS·Cardiology· 2026· 8 pagesThis document assesses the population health impact of the 2026 American Heart Association/American College of Cardiology/multisociety guideline on primary prevention statin therapy, focusing on changes in eligibility for statin therapy among nonpregnant adults aged 30 to 79 years.
CARDIOVASCULAR RISK RECLASSIFICATION WITH THE 2026 DYSLIPIDEMIA GUIDELINE coverClinical reviewsCARDIOVASCULAR RISK RECLASSIFICATION WITH THE 2026 DYSLIPIDEMIA GUIDELINEJohns Hopkins University School of Medicine; Johns Hopkins Bloomberg School of Public Health·Cardiology· 2026· 4 pagesThis document discusses the limitations of the 2013 pooled cohort equations for estimating cardiovascular risk and introduces the 2026 Dyslipidemia Guideline, which recommends the use of the new PREVENT equations for risk assessment.
PROSPECTIVE ANALYSIS OF NT PRO BNP LEVEL AS A PREDICTOR OF HOSPITAL RE ADMISSION IN HEART FAILURE PATIENTS coverClinical reviewsPROSPECTIVE ANALYSIS OF NT PRO BNP LEVEL AS A PREDICTOR OF HOSPITAL RE ADMISSION IN HEART FAILURE PATIENTSAdi Shankar Multi Speciality Hospital, Jabalpur, Madhya Pradesh, India·Cardiology· 2025· 6 pagesThis study assesses the predictive value of NT-proBNP levels for hospital readmission in patients with heart failure. It highlights the correlation between NT-proBNP levels and the risk of rehospitalization.
CHRONIC HEART FAILURE IN ADULTS: DIAGNOSIS AND MANAGEMENT coverGuidelines & protocolsCHRONIC HEART FAILURE IN ADULTS: DIAGNOSIS AND MANAGEMENTNational Institute for Health and Care Excellence (NICE)·Cardiology· 2018· 40 pagesThis guideline provides recommendations for the diagnosis and management of chronic heart failure in adults, emphasizing the importance of individual patient needs and preferences.
ASYMPTOMATIC DEGENERATIVE MITRAL REGURGITATION: A REVIEW coverClinical reviewsASYMPTOMATIC DEGENERATIVE MITRAL REGURGITATION: A REVIEWJAMA Cardiology·Cardiology· 2020· 10 pagesThis review discusses the management of asymptomatic patients with severe degenerative mitral regurgitation (DMR), emphasizing the challenges in timing surgical intervention.
HOLISTIC APPROACH TO MANAGING THE CARDIOLOGY PATIENT IN AFRICA coverLecture slidesHOLISTIC APPROACH TO MANAGING THE CARDIOLOGY PATIENT IN AFRICAPASCAR·Cardiology· 2025· 1 pagesThis document serves as a reminder for the PASCAR All Africa Cardiology Webinar Series 2025, focusing on a holistic approach to managing cardiology patients in Africa.
Anticoagulation for Atrial Fibrillation with Intermediate Stroke coverClinical reviewsAnticoagulation for Atrial Fibrillation with Intermediate StrokeDaehoon Kim, M.D.·Cardiology· 2026· 12 pagesA multicenter, open‑label, randomized trial in South Korea comparing direct oral anticoagulant (DOAC) therapy with no anticoagulation in patients with atrial fibrillation at intermediate stroke risk.
PreviousPage 15 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount